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doi:10.1016/j.pedneo.2011.11.012Leigh syndrome is an early-onset progressive neurodegenerative disorder with a characteristic
neuropathology consisting of focal, bilateral lesions in one or more areas of the central nervous
system. The brain images of Leigh syndrome are characterized by markedly symmetrical
involvement, most frequently of the putamen. We report a 2-year-old girl with Leigh syndrome
manifested as acute onset of altered level of consciousness. Brain magnetic resonance images
showed abnormal signal intensity over the bilateral basal ganglia and cerebellar dentate
nuclei. Despite normal biochemical studies, in particular serum lactate levels, magnetic reso-
nance spectroscopy demonstrated a downward doublet lactate peak. The diagnosis of Leigh
syndrome was subsequently confirmed by genetic study which showed a novel mutation at
8597T>C of the mitochondrial ATPase6 gene.
Copyright ª 2012, Taiwan Pediatric Association. Published by Elsevier Taiwan LLC. All rights
reserved.1. Introduction
Leigh syndrome (LS) is an inherited neurodegenerative
disease that presents itself as a rapidly progressive
phenotype and usually emerges in infancy and childhood.t of Pediatrics, Chung Shan
tion 1, Jianguo North Road,
w (J.-N. Sheu).
an Pediatric Association. PublishClinical presentations may vary, include change level of
consciousness, brain stem and cerebellar dysfunction that
result in stuporous, floppiness, hypertonicity and apneutic
respiration.1 Laboratory findings may show metabolic
acidosis with elevated lactate level in the brain or cere-
brospinal fluid (CSF).2,3
Magnetic resonance (MR) images in LS are characterized
by symmetrical T2 prolongation of the basal ganglia and
brainstem.2,3 MR spectroscopy in patients with LS may
reveal elevated lactate peak in the basal ganglia region,ed by Elsevier Taiwan LLC. All rights reserved.
A mitochondrial DNA 8597T>C mutation in LS 61which can help in detecting neurometabolic disease
including mitochondrial disease.4
Leigh syndrome is generally attributed to mutations in
mitochondrial or nuclear encoded genes. The most
frequently mutated mitochondrial gene is ATPase 6, which
encodes for a subunit of respiratory chain complex V.5 We
present a 2-year-old girl with this disorder bearing a novel
mutation in the mitochondrial ATPase 6 gene.
2. Case Report
A 2-year-old girl was the first child of nonconsanquineous
parents. She had normal birth history, and her developmental
was normal. At the age of 2 years old, she had pyretic illness,
with subsequent unstable gait for 2 days, altered level of
consciousness, respiratory failure and external oph-
thamoplegia. Her laboratory tests, including white blood cell
counts, C-reactive protein, electrolytes, ammonia, blood gas,
blood lactate and cerebrospinal fluid examination were
normal. Muscle biopsy with histochemistry stains showed
a normal result. Glucose lactate stimulation test was normal.
Assays of urinary organic acids and blood amino acids were
within normal limits. Brain MR imaging showed symmetric
abnormal signal intensity over the bilateral lentiform nuclei,
caudatenuclei,posteriorparts of the thalami, substantianigra
of the midbrain, posterior surface of the medulla oblongata,
and cerebellar dentate nuclei (Figure 1). Proton MR spectros-
copy demonstrated a downward doublet lactate peak
(Figure 2). Subsequently, molecular genetic analysis via
sequencing of the mitochondrial ATPase6 gene wasFigure 1 Axial brain MRI shows symmetrical high signal
intensities in the putamen (black arrows) and posterior parts of
thalami (white arrows). MRI Z magnetic resonance imaging.performed. Written informed consent was obtained from the
patient‘s parents. Total DNA was extracted from white blood
cells and skeletal muscle by using the Puregene DNA purifica-
tion kit (Qiagen, Valencia, CA, USA). The mitochondrial DNA,
including mitochondrial ATPase6, was amplified by poly-
merase chain reaction (PCR). Point mutations were searched
for the mitochondrial ATPase6 gene by direct sequencing of
the purified PCR products. Sequence analysis of the mito-
chondrial ATPase6 gene in the patient revealed a novel het-
eroplasmic T /C substitution at mt 8597(8597T>C) in
mitochondrialATPase6gene (Figure3).Themutationresults in
the substitution of a highly conserved isoleucine to threonine
at codon 24. The proportions of the mutation in the patient’s
blood and muscle specimens were greater than 95%.
After being diagnosed as a case of LS, the patient was
administrated with coenzyme-Q (30 mg/day). Thirty days
later, thepatientpresentedwith stupor, feedingdifficultyand
hypertonicity of four limbs. EEG showed generalized slowing
activities, prolonged latency of auditory evoked potentials
was found. The follow-up MR images on admission Day 30
revealed brain atrophy with encephalomalacia and hemor-
rhagic necrosis (Figure 4). At the age of 3 years old, she had
mental regression, feedingdifficulty and spastic quadriplegia.3. Discussion
Leigh syndrome, characterized by symmetrical necrosis in
the brain stem, basal ganglia and thalamus in infancy orFigure 2 MR spectroscopy shows a downward doublet, the
lactate peak over the putamen (arrow). MR Z magnetic
resonance.
Figure 3 Sequence analysis of mitochondrial ATPase6 gene
in the patient shows a mutation 8597T>C.
62 J.-D. Tsai et alchildhood, results from heterogeneous biochemical abnor-
malities in mitochondria.6 Although elevated lactate in
plasma or CSF is commonly seen in the patients with
mitochondrial diseases,7 the sensitivity of lactic acidemia
for the diagnosis of LS remains varied.2,3,5,6 Because mostFigure 4 Axial brain MRI shows generalized brain atrophy
and abnormal signal intensities over the bilateral lentiform
nuclei and white matter of the partieto-occipital regions, with
cystic change and high signal intensities (arrows).
MRI Z magnetic resonace imaging.other nonmitochondrial diseases that involve the basal
ganglia lack lactate doublet, spectroscopy may be useful
for diagnosing LS.8 In this case, though, the results of the
initial blood lactate level, analysis of blood gas, and glucose
lactate stimulation test were all were normal. The brain
magnetic imaging studies showed abnormal signal intensi-
ties over the basal ganglia; in addition, brain MR spectros-
copy also demonstrated elevated lactate peak at the onset
of the disease. Therefore, these findings in our case are
compatible with clinical manifestations of LS.
LS was reported to be mutated in mitochondrial or
nuclear coded genes. Mutation of mitochondrial genes to
manifest clinically requires a certain heteroplasmy rate.9
The most frequently mutated mitochondrial gene in LS is
ATPase6 gene, which encodes in the subunit of respiratory
chain complex V. The most frequently reported mitochon-
drial ATPase6 genes were transversion 8993T>C and
8993T>G. A less common mutation in ATPase6 gene is
9176T>C, which was initially described in two familial
siblings with bilateral striatal necrosis but a relatively non-
progress course.5 In contrast to the milder phenotype,
Dionisi-Vici et al10 reported a more fulminant clinical course
in a family with two siblings, who presented as sudden
unexpected death in infancy. Their symptoms developed
during the first years of life without specific signs.
Symmetrical spongiform of the brain, mainly affecting the
basal ganglia and brain stem, and subsequent poor prognosis
were noticed; these features resemble those of our case.
In conclusion, the finding of the novel mutation at
mt8597T>C may expand the spectrum of mutation in mito-
chondrial genes with subsequent LS. MR spectroscopy of the
brain may be helpful in diagnosis of LS without lacticemia.
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